University of Birmingham spin-out secures £800k insidermedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermedia.com Daily Mail and Mail on Sunday newspapers.
2021/02/25 22:00
SINGAPORE - Media OutReach - 25 February 2021 - UK-based neuromuscular medical device company, GyroGear Ltd has just concluded phase one of its seed round fundraise. This round was led by Foxconn Technology Group, the world s largest and foremost electronics manufacturer. Foxconn has invested £1 million (US$1.41 million) upfront. Participants in GyroGear s seed round include the UK Government Future Fund, Singapore venture builder Fidelium Group, and other established strategic investors and business leaders. Phase two of the seed round is ongoing and scheduled for completion in March 2021.
Chairman Young-way Liu (right) and Dr Faii Ong (left) at Foxconn Technology Group, Taipei.
GyroGear is developing a wearable to help individuals with hand tremors. The wearable reduces tremors, so they may perform their day-to-day activities. This also brings relief to caregivers and family members.
(2)
DJ Medtech Startup GyroGear raises USUSD4.3m in Phase One of Seed Round led by Taiwan Manufacturing Giant Foxconn
GyroGear Ltd.
Medtech Startup GyroGear raises USUSD4.3m in Phase One of Seed Round led by Taiwan Manufacturing Giant Foxconn
25-Feb-2021 / 15:25 GMT/BST
=
Medtech Startup GyroGear raises USUSD4.3m in Phase One of Seed Round
led by Taiwan Manufacturing Giant Foxconn
SINGAPORE - Media OutReach - 25 February 2021 - UK-based neuromuscular medical device company, GyroGear Ltd has just
concluded phase one of its seed round fundraise. This round was led by Foxconn Technology Group, the world s largest
and foremost electronics manufacturer. Foxconn has invested GBP1 million (USUSD1.41 million) upfront. Participants in
UK s Linear Diagnostics secures £800k for point of care diagnostics platform
UK s Linear Diagnostics secures £800k for point of care diagnostics platform 24 February 2021 | News The funds received by the University of Birmingham spinout will enable Linear Diagnostics to develop a prototype single-use cartridge and reader for our duplex test for chlamydia and gonorrhoea
Photo Credit: Freepik
Birmingham-based Linear Diagnostics Ltd has secured £800,000 from the Midlands Engine Investment Fund (MEIF) and other investors in the company’s second round of funding, which will enable the company to commence the development of the hardware platform for its tests
.
The finance will facilitate the ongoing development of the company’s high-speed platform technology for point-of-care diagnostics. The funding package includes backing from MEIF Equity Finance, managed by venture capital firm Midven, the University of Birmingham and the UKI2S Fund. The UK Futu